Germline variants in the CDKN2A/B loci have also been previously associated with risk of developing OSA in high-risk dog breeds [57] and also of developing histiocytic sarcoma in Bernese Mountain dogs [58]. Here, CDKN2A is linked to histiocytic sarcoma.